Who We Help
Advancing Eye Care Across Every Stage of the Patient Journey
Ophthalytics supports healthcare providers, researchers, and organizations through AI-powered solutions designed for screening, diagnosis, and clinical research.
From primary care to optometry to pharmaceutical trials, our products are built to address real-world gaps in detection, decision-making, and patient access.
Nsight360
For Primary Care, Population Health, and Screening Programs
Bringing retinal screening to the frontlines of care
Nsight360 is designed for healthcare providers who want to deliver accessible, efficient retinal screening at the point of care. By enabling non-specialists to perform eye exams, it expands access and helps close critical care gaps.
Who it's for
Primary Care Physicians 
Endocrinologists & Diabetologists 
Nurses & Care Teams 
Home Health Agencies 
Community Health Centers 
Remote & Rural Clinics How it helps
- •Enables retinal screening without requiring an on-site eye specialist
- •Expands access to underserved populations
- •Supports early detection of diabetic retinopathy
- •Improves workflow efficiency and patient throughput
- •Helps close care gaps and improve quality measures
Nsight360 makes it possible to identify at-risk patients earlier—where they already receive care.
2nd Opinion
For Optometrists and Eye Care Professionals
Enhancing confidence in retinal assessments
2nd Opinion is built for optometrists and eye care providers who want additional support in interpreting retinal images, especially in complex or borderline cases.
Who it's for
Optometrists 
Eye Clinics & Optical Chains 
Ophthalmology Practices 
Reading Centers How it helps
- •Highlights suspicious regions and potential lesions
- •Supports clinical decision-making in uncertain cases
- •Reduces variability in retinal interpretation
- •Integrates seamlessly into existing workflows
In everyday practice, not every case is clear-cut. 2nd Opinion provides an added layer of insight—helping clinicians see more and decide with greater confidence.
Ophthal360
For High-Volume Screening and Autonomous Deployment
Autonomous AI for scale and reach
Ophthal360 is designed for organizations delivering retinal screening at scale—healthcare systems, large screening programs, and partners serving high-volume markets. Currently in active deployment in Asian markets, Ophthal360 enables rapid, consistent detection with minimal manual intervention.
Who it's for
Healthcare Systems 
Population Health Programs 
Pharmaceutical Companies 
Clinical Research Organizations 
Imaging Centers 
Academic & Research Institutions How it helps
- •Performs retinal analysis and generates screening outputs without manual interpretation
- •Optimized for large-scale deployment in clinics, screening programs, and population health initiatives
- •Identifies at-risk patients and supports timely referral decisions
- •Accelerates recruitment and enrollment timelines for trials
- •Supports consistent evaluation across sites and geographies
Ophthal360 makes it possible to deliver screening coverage at a scale no specialist-dependent model can match.
From Screening to Diagnosis to Discovery
Together, our products support the full continuum of eye care:
Screening
Nsight360
Bring retinal screening to the frontlines of care.
Diagnostic Support
2nd Opinion
Enhance clinical confidence in complex cases.
Scale & Discovery
Ophthal360
Autonomous screening for high-volume programs.
This integrated approach enables earlier detection, better decisions, and faster advancements in eye health.
National Impact
National Impact
Redefining American Eye Care Through Intelligence
Ophthalytics is advancing the future of preventive eye care across the United States — partnering with health systems, community clinics, and policymakers to bring AI-powered retinal screening to the populations that need it most.
From Congressional telehealth showcases to federally qualified health centers, our technology is earning recognition as a critical tool in closing the diabetic eye care gap in America.
partnerships
compliance
International Impact
International Impact
Transforming Diabetic Care Across Pakistan
Recognizing the crucial need to reach underserved communities, we have forged powerful partnerships to amplify our impact. Through dynamic collaborations with The Diabetes Centre and the Layton Rahmatulla Benevolent Trust, we are bringing our services to rural and marginalized populations in Pakistan.
By harnessing Nsight360, we are breaking down barriers to access, ensuring that individuals in these communities receive the essential diabetic eye exams they deserve.
screened
partners
Find the Right Solution for Your Practice
Whether you are delivering care, supporting diagnosis, or advancing research, Ophthalytics provides AI-powered tools designed for your needs.